2024-04-16  9:43:23 PM Chg. -0.48 Volume Bid9:44:02 PM Ask- Market Capitalization Dividend Y. P/E Ratio
40.02USD -1.19% 92,700
Turnover: 3.71 mill.
40.02Bid Size: 400 -Ask Size: - 74.42 bill.USD - -

Business description

GSK is a british pharmaceutical and healthcare company. GSK manufactures drugs and vaccines for major disease areas such as asthma, cancer, infections, diabetes, digestive and mental health conditions. Many medicines were historically discovered or developed at GSK and its predecessor companies and are now sold as generics.
 

Management board & Supervisory board

CEO
Emma Walmsley
Management board
Julie Brown, Diana Conrad, James Ford, Luke Miels, Sally Jackson, Tony Wood, Shobie Ramakrishnan, David Redfern, Regis Simard, Phil Thomson, Deborah Waterhouse
Supervisory board
Jonathan Symonds, Emma Walmsley, Iain Mackay, Elizabeth (Liz) McKee Anderson, Charles Bancroft, Dr. Hal Barron, Dr. Anne Beal, Dr. Harry (Hal) C Dietz, Dr. Jesse Goodman, Urs Rohner, Dr. Vishal Sikka, Wendy Becker, Dr. Jeannie Lee
 

Company data

Name: GlaxoSmithKline PLC
Address: 980 Great West Road,UK-Brentford, Middlesex TW8 9GS
Phone: +44-20-8047-5000
Fax: -
E-mail: -
Internet: www.gsk.com
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12-31
Free Float: 41.74%
IPO date: -

Investor relations

Name: Nick Stone
IR phone: +44 7717 618834
IR Fax: -
IR e-mail: GSK.Investor-Relations@gsk.com

Company calendar

CW 18 | 2024-05-01 Interim Report 1st Quarter/3 Months
CW 31 | 2024-07-31 Interim Report 2nd Quarter/6 Months
CW 44 | 2024-10-30 Interim Report 3rd Quarter/9 Months
CW 6 | 2025-02-05 Report 4th Quarter
 

Main Shareholders